Skip to main content
profile image
Selected Works of Walter J. Urba, MD, PhD
Article
Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma
Journal of Clinical Oncology (2008)
  • Jeffrey A. Sosman, Vanderbilt University
  • Carole Carrillo, Vanderbilt University
  • Walter J. Urba, Vanderbilt University
  • Lawrence Flaherty, Vanderbilt University
  • Michael B. Atkins, Vanderbilt University
  • Joseph I. Clark, Vanderbilt University
  • Janet Dutcher, Vanderbilt University
  • Kim A. Margolin, Vanderbilt University
  • James Mier, Vanderbilt University
  • Jarod Gollob, Vanderbilt University
  • John M. Kirkwood, Vanderbilt University
  • David J. Panka, Vanderbilt University
  • Nancy A. Crosby, Vanderbilt University
  • Kevin O'Boyle, Vanderbilt University
  • Bonnie LaFleur, Vanderbilt University
  • Marc S. Ernstoff, Vanderbilt University
Link
Disciplines
Publication Date
May 10, 2008
DOI
10.1200/JCO.2007.13.3165
Citation Information
Jeffrey A. Sosman, Carole Carrillo, Walter J. Urba, Lawrence Flaherty, et al.. "Three Phase II Cytokine Working Group Trials of gp100 (210M) Peptide Plus High-Dose Interleukin-2 in Patients With HLA-A2–Positive Advanced Melanoma" Journal of Clinical Oncology Vol. 26 Iss. 14 (2008) p. 2292 - 2298
Available at: http://works.bepress.com/walter-urba/4/